Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop.
作者信息
Simon Alan E, Freund Michelle P, Archer Stephanie Wilson, Bremer Andrew A
机构信息
Office of the Director, National Institutes of Health, Bethesda, MD, 20892, USA.
National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, 20892, USA.
出版信息
J Perinatol. 2021 Jun;41(6):1213-1215. doi: 10.1038/s41372-020-00886-7. Epub 2021 Jan 25.
Abstract
摘要
相似文献
1
Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop.关于在婴儿中使用丁丙诺啡治疗新生儿阿片类药物戒断综合征：美国国立卫生研究院研讨会综述
J Perinatol. 2021 Jun;41(6):1213-1215. doi: 10.1038/s41372-020-00886-7. Epub 2021 Jan 25.
2
Management of neonatal abstinence syndrome from opioids.管理新生儿阿片类药物戒断综合征。
Clin Perinatol. 2013 Sep;40(3):509-24. doi: 10.1016/j.clp.2013.05.004. Epub 2013 Jul 17.
3
Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome.描述用于治疗新生儿阿片类药物戒断综合征的丁丙诺啡药效学的生理间接反应建模。
Clin Pharmacokinet. 2021 Feb;60(2):249-259. doi: 10.1007/s40262-020-00939-2.
4
Neonatal opioid withdrawal syndrome.新生儿阿片类戒断综合征。
Obstet Gynecol Clin North Am. 2014 Jun;41(2):317-34. doi: 10.1016/j.ogc.2014.02.010.
5
Prenatal Opioid Maintenance in the United States and Its Effect on Neonatal Abstinence Syndrome: The Case of West Virginia's Opioid Epidemic.美国的产前阿片类药物维持治疗及其对新生儿戒断综合征的影响：以西弗吉尼亚州的阿片类药物流行情况为例
Health Care Manag (Frederick). 2019 Jul/Sep;38(3):258-266. doi: 10.1097/HCM.0000000000000268.
6
Buprenorphine: a new player in neonatal withdrawal syndrome.丁丙诺啡：新生儿戒断综合征的新角色。
W V Med J. 2015 Jan-Feb;111(1):16-21.
7
A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.丁丙诺啡与美沙酮治疗新生儿戒断综合征的队列比较
J Pediatr. 2016 Mar;170:39-44.e1. doi: 10.1016/j.jpeds.2015.11.039. Epub 2015 Dec 15.
8
Buprenorphine: a newer drug for treating neonatal abstinence syndrome.丁丙诺啡：一种治疗新生儿戒断综合征的新药。
Neonatal Netw. 2012 May-Jun;31(3):178-83. doi: 10.1891/0730-0832.31.3.178.
9
Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine.在接受丁丙诺啡维持治疗的阿片类药物依赖孕妇中，孕晚期接触大麻后的母婴结局。
Drug Alcohol Depend. 2017 Nov 1;180:200-203. doi: 10.1016/j.drugalcdep.2017.08.012. Epub 2017 Sep 7.
10
Eat, Sleep, Console and Adjunctive Buprenorphine Improved Outcomes in Neonatal Opioid Withdrawal Syndrome.进食、睡眠、安抚和辅助丁丙诺啡可改善新生儿阿片类药物戒断综合征的结局。
Adv Neonatal Care. 2021 Feb 1;21(1):41-48. doi: 10.1097/ANC.0000000000000824.
引用本文的文献
1
Development and Verification of a Full Physiologically Based Pharmacokinetic Model for Sublingual Buprenorphine in Healthy Adult Volunteers that Accounts for Nonlinear Bioavailability.经口丁丙诺啡生理药代动力学模型的建立与验证：考虑到非线 性生物利用度，该模型适用于健康成年志愿者
Drug Metab Dispos. 2024 Jul 16;52(8):785-796. doi: 10.1124/dmd.124.001643.
2
Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling.通过基于生理药代动力学模型的母胎模型预测胎儿丁丙诺啡暴露情况。
Pharmaceutics. 2024 Mar 8;16(3):375. doi: 10.3390/pharmaceutics16030375.
3
Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.基于生理学的药代动力学模型研究新生儿阿片类戒断综合征中成熟对丁丙诺啡药代动力学的影响。
Clin Pharmacol Ther. 2022 Feb;111(2):496-508. doi: 10.1002/cpt.2458. Epub 2021 Nov 21.
Zotero 插件